281 related articles for article (PubMed ID: 17029886)
1. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity.
Toubi E; Gordon S; Kessel A; Rosner I; Rozenbaum M; Shoenfeld Y; Zuckerman E
J Autoimmun; 2006 Sep; 27(2):134-9. PubMed ID: 17029886
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies.
Atta AM; Oliveira IS; Sousa GM; Paraná R; Atta ML
Microb Pathog; 2010 Feb; 48(2):53-6. PubMed ID: 20005287
[TBL] [Abstract][Full Text] [Related]
4. The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.
Toubi E; Kessel A; Rosner I; Rozenbaum M; Paran D; Shoenfeld Y
Scand J Immunol; 2006 Apr; 63(4):299-303. PubMed ID: 16623930
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum BAFF levels in patients with autoimmune hepatitis.
Migita K; Abiru S; Maeda Y; Nakamura M; Komori A; Ito M; Fujiwara S; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Hum Immunol; 2007 Jul; 68(7):586-91. PubMed ID: 17584580
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus.
Ramos-Casals M; Font J; García-Carrasco M; Cervera R; Jiménez S; Trejo O; de la Red G; Sánchez-Tapias JM; Ingelmo M
Arthritis Rheum; 2000 Dec; 43(12):2801-6. PubMed ID: 11145039
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
[TBL] [Abstract][Full Text] [Related]
8. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
[TBL] [Abstract][Full Text] [Related]
9. BAFF is elevated in serum of patients with Wegener's granulomatosis.
Krumbholz M; Specks U; Wick M; Kalled SL; Jenne D; Meinl E
J Autoimmun; 2005 Dec; 25(4):298-302. PubMed ID: 16242914
[TBL] [Abstract][Full Text] [Related]
10. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.
Ramos-Casals M; Jara LJ; Medina F; Rosas J; Calvo-Alen J; Mañá J; Anaya JM; Font J;
J Intern Med; 2005 Jun; 257(6):549-57. PubMed ID: 15910559
[TBL] [Abstract][Full Text] [Related]
11. B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection.
Fabris M; Quartuccio L; Sacco S; De Marchi G; Pozzato G; Mazzaro C; Ferraccioli G; Migone TS; De Vita S
Rheumatology (Oxford); 2007 Jan; 46(1):37-43. PubMed ID: 16735452
[TBL] [Abstract][Full Text] [Related]
12. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
14. Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection.
Tarantino G; Marco VD; Petta S; Almasio PL; Barbaria F; Licata A; Bosco GL; Tripodo C; Stefano RD; Craxì A
J Viral Hepat; 2009 Jun; 16(6):397-405. PubMed ID: 19200135
[TBL] [Abstract][Full Text] [Related]
15. Arthritis in patients with chronic hepatitis C virus infection.
Rivera J; García-Monforte A; Pineda A; Millán Núñez-Cortés J
J Rheumatol; 1999 Feb; 26(2):420-4. PubMed ID: 9972979
[TBL] [Abstract][Full Text] [Related]
16. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity.
Kessel A; Elias G; Pavlotzky E; Zuckerman E; Rosner I; Toubi E
Hum Immunol; 2007 Oct; 68(10):844-8. PubMed ID: 17961773
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in systemic lupus erythematosus: a case-control study.
Perlemuter G; Cacoub P; Sbaï A; Hausfater P; Thibault V; Le TH; Wechsler B; Buffet C; Piette JC
J Rheumatol; 2003 Jul; 30(7):1473-8. PubMed ID: 12858443
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke.
Cojocaru IM; Cojocaru M; Iacob SA
Rom J Intern Med; 2005; 43(1-2):89-95. PubMed ID: 16739869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]